Table 2. Association between baseline glycemic traits and baseline BMI and change in BMI over 3.3 years.
| BMI |
||
|---|---|---|
| Baseline | Change | |
| aIFG/IGT | 0.34 ± 0.02(1.35 × 10−98) | −0.13 ± 0.03b(3.65 × 10−7) |
| aT2D | 0.44 ± 0.02(5.25 × 10−80) | −0.34 ± 0.04b(1.06 × 10−19) |
| FPG | 0.19 ± 0.01(1.80 × 10−145) | −0.09 ± 0.01b(8.47 × 10−14) |
| 2hPG | 0.20 ± 0.01(4.26 × 10−159) | −0.10 ± 0.01b(1.28 × 10−19) |
NGT = Normal glucose tolerance; IFG = Impaired fasting glucose; IGT = Impaired glucose tolerance; T2D = Type 2 Diabetes; BMI = Body mass Index; FPG = fasting plasma glucose; 2hPG = two hour plasma glucose. P value < 6.3 × 10−3 (0.05/8) are statistically significant; data are presented as B ± SE (P-value). aNGT used as the reference group. Adjusted for sex, age and population stratification/ethnicity and brandomization to thiazolidinedione after baseline. Linear regression analysis was performed.